SST and coronary artery disorder: Serum SST concentrations were significantly increased in patients with CAD and displayed a decreased trend in patients with CAD recovery (control: 4.87 ± 0.43 ng ml−1; CAD: 6.31 ± 0.45 ng ml−1; CAD recovery: 5.92 ± 0.24 ng ml−1, p < 0.05).